General Information of the Cell Line
Cell Line ID
CL000113
Cell Line Name
SW620/AD300
Synonyms
SW620/AD-300
SW620/Ad300
SW620 Ad300
Ad300
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_ZZ39
Tissue Information
Lymph node
Disease
Colon adenocarcinoma (NCIt: C4349)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01546, ATP-dependent translocase ABCB1
Compound ID Compound Name Compound Formula
CP0437560
(E)-3-[6-(3-chloro-4-pyridin-2-ylphenoxy)pyridin-3-yl]-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]prop-2-enamide
   Show/Hide
C38H35ClN4O4
 2
1
EC50 = 37.2 nM
   TI
   LI
   LO
   TS
2
IC50 = 560 nM
   TI
   LI
   LO
   TS
CP0391451
(E)-3-[6-(3-cyano-4-pyridin-2-ylphenoxy)pyridin-3-yl]-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]prop-2-enamide
   Show/Hide
C39H35N5O4
 2
1
EC50 = 51 nM
   TI
   LI
   LO
   TS
2
IC50 = 610 nM
   TI
   LI
   LO
   TS
CP0437791
(E)-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-[6-(4-pyridin-3-ylphenoxy)pyridin-3-yl]prop-2-enamide
   Show/Hide
C38H36N4O4
 2
1
EC50 = 103.4 nM
   TI
   LI
   LO
   TS
2
IC50 = 390 nM
   TI
   LI
   LO
   TS
CP0577510
(3R,11S,11aS)-2-acetyl-3-benzoyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-3,4,11,11a-tetrahydro-1H-pyrazino[1,2-b]isoquinolin-6-one
   Show/Hide
C29H26N2O6
 1
1
IC50 = 220 nM
   TI
   LI
   LO
   TS
CP0575134
(8S,10aS,11R)-9-acetyl-8-benzyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-8,10,10a,11-tetrahydro-7H-pyrazino[1,2-g][1,6]naphthyridin-5-one
   Show/Hide
C28H27N3O5
 1
1
IC50 = 270 nM
   TI
   LI
   LO
   TS
CP0489344
(5S,5aS,8S)-7-acetyl-8-benzoyl-5-(7-methoxy-1,3-benzodioxol-5-yl)-5a,6,8,9-tetrahydro-5H-pyrazino[2,1-g][1,7]naphthyridin-11-one
   Show/Hide
C28H25N3O6
 1
1
IC50 = 280 nM
   TI
   LI
   LO
   TS
CP0571947
(8R,10aS,11R)-9-acetyl-8-benzoyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-8,10,10a,11-tetrahydro-7H-pyrazino[1,2-g][1,6]naphthyridin-5-one
   Show/Hide
C28H25N3O6
 1
1
IC50 = 280 nM
   TI
   LI
   LO
   TS
CP0575297
(5S,5aS,8R)-7-acetyl-8-benzoyl-5-(7-methoxy-1,3-benzodioxol-5-yl)-5a,6,8,9-tetrahydro-5H-pyrazino[2,1-g][1,7]naphthyridin-11-one
   Show/Hide
C28H25N3O6
 1
1
IC50 = 280 nM
   TI
   LI
   LO
   TS
CP0534311
(3S,11S,11aS)-2-acetyl-3-benzyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-3,4,11,11a-tetrahydro-1H-pyrazino[1,2-b][2,7]naphthyridin-6-one
   Show/Hide
C28H27N3O5
 1
1
IC50 = 290 nM
   TI
   LI
   LO
   TS
CP0571895
(3S,11S,11aS)-2-acetyl-3-benzyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-3,4,11,11a-tetrahydro-1H-pyrazino[1,2-b]isoquinolin-6-one
   Show/Hide
C29H28N2O5
 1
1
IC50 = 310 nM
   TI
   LI
   LO
   TS
CP0535459
(5S,5aS)-7-acetyl-5-(7-methoxy-1,3-benzodioxol-5-yl)-5a,6-dihydro-5H-pyrazino[2,1-g][1,7]naphthyridin-11-one
   Show/Hide
C21H19N3O5
 1
1
IC50 = 330 nM
   TI
   LI
   LO
   TS
CP0539724
1-[(2R,3S,6S,10R,11S)-13-methoxy-6-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-11-phenyl-15,17-dioxa-5,8-diazapentacyclo[10.7.0.02,10.03,8.014,18]nonadeca-1(19),12,14(18)-trien-5-yl]ethanone
   Show/Hide
C33H34N2O7
 1
1
IC50 = 350 nM
   TI
   LI
   LO
   TS
CP0542871
(2R,3S,6S,10R,11S)-5-acetyl-13-methoxy-6-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-11-phenyl-15,17-dioxa-5,8-diazapentacyclo[10.7.0.02,10.03,8.014,18]nonadeca-1(19),12,14(18)-trien-9-one
   Show/Hide
C33H32N2O8
 1
1
IC50 = 350 nM
   TI
   LI
   LO
   TS
CP0574392
(5S,5aS,8S)-7-acetyl-8-benzyl-5-(7-methoxy-1,3-benzodioxol-5-yl)-5a,6,8,9-tetrahydro-5H-pyrazino[2,1-g][1,7]naphthyridin-11-one
   Show/Hide
C28H27N3O5
 1
1
IC50 = 350 nM
   TI
   LI
   LO
   TS
CP0420976
(E)-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-[6-(3-methyl-4-pyridin-2-ylphenoxy)pyridin-3-yl]prop-2-enamide
   Show/Hide
C39H38N4O4
 1
1
IC50 = 490 nM
   TI
   LI
   LO
   TS
CP0574393
(5S,5aS,8S)-5-(7-methoxy-1,3-benzodioxol-5-yl)-8-(1-phenylethenyl)-5,5a,6,7,8,9-hexahydropyrazino[2,1-g][1,7]naphthyridin-11-one
   Show/Hide
C27H25N3O4
 1
1
IC50 = 540 nM
   TI
   LI
   LO
   TS
CP0521003
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-2-(1-methyl-2-phenylindol-3-yl)-2-morpholin-4-ylacetamide
   Show/Hide
C40H44N4O4
 1
1
IC50 = 550 nM
   TI
   LI
   LO
   TS
CP0524626
(E)-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-(3-methyl-5-pyridin-2-yl-2-pyridin-2-yloxyphenyl)prop-2-enamide
   Show/Hide
C39H38N4O4
 1
1
IC50 = 550 nM
   TI
   LI
   LO
   TS
CP0571945
(5S,5aS,8S)-8-benzoyl-5-(7-methoxy-1,3-benzodioxol-5-yl)-5,5a,6,7,8,9-hexahydropyrazino[2,1-g][1,7]naphthyridin-11-one
   Show/Hide
C26H23N3O5
 1
1
IC50 = 580 nM
   TI
   LI
   LO
   TS
CP0574391
(5S,5aS,8R)-8-benzoyl-5-(7-methoxy-1,3-benzodioxol-5-yl)-5,5a,6,7,8,9-hexahydropyrazino[2,1-g][1,7]naphthyridin-11-one
   Show/Hide
C26H23N3O5
 1
1
IC50 = 580 nM
   TI
   LI
   LO
   TS
CP0570872
(10aS,11R)-9-acetyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-10a,11-dihydro-10H-pyrazino[1,2-g][1,6]naphthyridin-5-one
   Show/Hide
C21H19N3O5
 1
1
IC50 = 600 nM
   TI
   LI
   LO
   TS
CP0036382
CAS_52-53-9
   Show/Hide
C27H38N2O4
 5
1
IC50 = 630 nM
   TI
   LI
   LO
   TS
2
IC50 = 710 nM
   TI
   LI
   LO
   TS
3
IC50 = 810 nM
   TI
   LI
   LO
   TS
4
IC50 = 2980 nM
   TI
   LI
   LO
   TS
5
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0437559
(E)-3-[6-(2-bromo-4-pyridin-2-ylphenoxy)pyridin-3-yl]-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]prop-2-enamide
   Show/Hide
C38H35BrN4O4
 1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0417462
(E)-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-[6-(2-methyl-4-pyridin-2-ylphenoxy)pyridin-3-yl]prop-2-enamide
   Show/Hide
C39H38N4O4
 1
1
IC50 = 740 nM
   TI
   LI
   LO
   TS
CP0473128
(E)-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-[6-(3-pyridin-2-ylphenoxy)pyridin-3-yl]prop-2-enamide
   Show/Hide
C38H36N4O4
 1
1
IC50 = 750 nM
   TI
   LI
   LO
   TS
CP0417463
(E)-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-[6-(2-iodo-4-pyridin-2-ylphenoxy)pyridin-3-yl]prop-2-enamide
   Show/Hide
C38H35IN4O4
 1
1
IC50 = 760 nM
   TI
   LI
   LO
   TS
CP0420977
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-2-[6-(4-pyridin-2-ylphenoxy)pyridin-3-yl]cyclopropane-1-carboxamide
   Show/Hide
C39H38N4O4
 1
1
IC50 = 760 nM
   TI
   LI
   LO
   TS
CP0542875
(2R,3S,6S,10R,11S)-13-methoxy-6-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-11-phenyl-15,17-dioxa-5,8-diazapentacyclo[10.7.0.02,10.03,8.014,18]nonadeca-1(19),12,14(18)-triene
   Show/Hide
C31H32N2O6
 1
1
IC50 = 770 nM
   TI
   LI
   LO
   TS
CP0543935
(3R,11S,11aS)-3-benzoyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-1,2,3,4,11,11a-hexahydropyrazino[1,2-b][2,6]naphthyridin-6-one
   Show/Hide
C26H23N3O5
 1
1
IC50 = 770 nM
   TI
   LI
   LO
   TS
CP0571896
(3S,11S,11aS)-3-benzoyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-1,2,3,4,11,11a-hexahydropyrazino[1,2-b][2,6]naphthyridin-6-one
   Show/Hide
C26H23N3O5
 1
1
IC50 = 770 nM
   TI
   LI
   LO
   TS
CP0520980
(E)-3-[6-(3,5-dihydroxy-4-pyridin-2-ylphenoxy)pyridin-3-yl]-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]prop-2-enamide
   Show/Hide
C38H36N4O6
 1
1
IC50 = 780 nM
   TI
   LI
   LO
   TS
CP0577025
(11S,11aS)-2-acetyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-11,11a-dihydro-1H-pyrazino[1,2-b]isoquinolin-6-one
   Show/Hide
C22H20N2O5
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0416401
(2R,3S,6S,10S,11S)-5-acetyl-6-benzyl-10-hydroxy-13-methoxy-11-phenyl-15,17-dioxa-5,8-diazapentacyclo[10.7.0.02,10.03,8.014,18]nonadeca-1(19),12,14(18)-trien-9-one
   Show/Hide
C31H30N2O6
 1
1
IC50 = 820 nM
   TI
   LI
   LO
   TS
CP0437790
(E)-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-(1-methyl-2-phenylpyrrolo[2,3-b]pyridin-3-yl)prop-2-enamide
   Show/Hide
C36H36N4O3
 1
1
IC50 = 820 nM
   TI
   LI
   LO
   TS
CP0521337
(E)-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-[6-(3-hydroxy-4-pyridin-2-ylphenoxy)pyridin-3-yl]prop-2-enamide
   Show/Hide
C38H36N4O5
 1
1
IC50 = 820 nM
   TI
   LI
   LO
   TS
CP0576785
(11S,11aS)-2-acetyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-11,11a-dihydro-1H-pyrazino[1,2-b][2,7]naphthyridin-6-one
   Show/Hide
C21H19N3O5
 1
1
IC50 = 840 nM
   TI
   LI
   LO
   TS
CP0396931
1-[(2R,3S,6S,10S,11S)-10-hydroxy-13-methoxy-6-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-11-phenyl-15,17-dioxa-5,8-diazapentacyclo[10.7.0.02,10.03,8.014,18]nonadeca-1(19),12,14(18)-trien-5-yl]ethanone
   Show/Hide
C33H34N2O8
 1
1
IC50 = 880 nM
   TI
   LI
   LO
   TS
CP0496307
(2R,3S,6S,10S,11S)-5-acetyl-10-hydroxy-13-methoxy-6-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-11-phenyl-15,17-dioxa-5,8-diazapentacyclo[10.7.0.02,10.03,8.014,18]nonadeca-1(19),12,14(18)-trien-9-one
   Show/Hide
C33H32N2O9
 1
1
IC50 = 880 nM
   TI
   LI
   LO
   TS
CP0535457
(3R,11S,11aS)-2-acetyl-3-benzoyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-3,4,11,11a-tetrahydro-1H-pyrazino[1,2-b][2,6]naphthyridin-6-one
   Show/Hide
C28H25N3O6
 1
1
IC50 = 940 nM
   TI
   LI
   LO
   TS
CP0575135
(3S,11S,11aS)-2-acetyl-3-benzoyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-3,4,11,11a-tetrahydro-1H-pyrazino[1,2-b][2,6]naphthyridin-6-one
   Show/Hide
C28H25N3O6
 1
1
IC50 = 940 nM
   TI
   LI
   LO
   TS
CP0542874
(3R,11S,11aS)-3-benzoyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-1,2,3,4,11,11a-hexahydropyrazino[1,2-b]isoquinolin-6-one
   Show/Hide
C27H24N2O5
 1
1
IC50 = 950 nM
   TI
   LI
   LO
   TS
CP0574394
(3S,11S,11aS)-11-(7-methoxy-1,3-benzodioxol-5-yl)-3-(1-phenylethenyl)-1,2,3,4,11,11a-hexahydropyrazino[1,2-b][2,6]naphthyridin-6-one
   Show/Hide
C27H25N3O4
 1
1
IC50 = 970 nM
   TI
   LI
   LO
   TS
CP0460826
(E)-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-[6-(4-pyridin-2-ylphenoxy)pyridin-2-yl]prop-2-enamide
   Show/Hide
C38H36N4O4
 1
1
IC50 = 990 nM
   TI
   LI
   LO
   TS
CP0489345
(3S,11S,11aS)-2-acetyl-3-benzyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-3,4,11,11a-tetrahydro-1H-pyrazino[1,2-b][2,6]naphthyridin-6-one
   Show/Hide
C28H27N3O5
 1
1
IC50 = 1010 nM
   TI
   LI
   LO
   TS
CP0544225
2-[(3S,14S)-12-hydroxy-3-[(1R)-1-hydroxyethyl]-14-methyl-10-oxo-15-oxa-2-azapentacyclo[9.7.1.02,6.07,19.013,18]nonadeca-1(19),6,8,11,13(18),16-hexaen-16-yl]acetic acid
   Show/Hide
C22H21NO6
 1
1
IC50 = 1010 nM
   TI
   LI
   LO
   TS
CP0496309
(11S,11aS)-2-acetyl-11-(7-methoxy-1,3-benzodioxol-5-yl)-11,11a-dihydro-1H-pyrazino[1,2-b][2,6]naphthyridin-6-one
   Show/Hide
C21H19N3O5
 1
1
IC50 = 1030 nM
   TI
   LI
   LO
   TS
CP0528668
(2R,3S,6S,10R,11S)-6-benzyl-13-methoxy-11-phenyl-15,17-dioxa-5,8-diazapentacyclo[10.7.0.02,10.03,8.014,18]nonadeca-1(19),12,14(18)-trien-9-one
   Show/Hide
C29H28N2O4
 1
1
IC50 = 1030 nM
   TI
   LI
   LO
   TS
CP0572592
(3S,11S,11aS)-11-(7-methoxy-1,3-benzodioxol-5-yl)-3-(1-phenylethenyl)-1,2,3,4,11,11a-hexahydropyrazino[1,2-b]isoquinolin-6-one
   Show/Hide
C28H26N2O4
 1
1
IC50 = 1050 nM
   TI
   LI
   LO
   TS
CP0532246
(2R,3S,6S,10R,11S)-5-acetyl-6-benzyl-13-methoxy-11-phenyl-15,17-dioxa-5,8-diazapentacyclo[10.7.0.02,10.03,8.014,18]nonadeca-1(19),12,14(18)-trien-9-one
   Show/Hide
C31H30N2O5
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0475228
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-2-hydroxy-2-(1-methyl-2-phenylindol-3-yl)acetamide
   Show/Hide
C36H37N3O4
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0437558
(E)-3-[6-(2,6-diiodo-4-pyridin-2-ylphenoxy)pyridin-3-yl]-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]prop-2-enamide
   Show/Hide
C38H34I2N4O4
 1
1
IC50 = 1180 nM
   TI
   LI
   LO
   TS
CP0564287
methyl 2-[(3S,14S,16R)-12-hydroxy-3-[(1R)-1-hydroxyethyl]-14-methyl-10-oxo-15-oxa-2-azapentacyclo[9.7.1.02,6.07,19.013,18]nonadeca-1(19),6,8,11,13(18)-pentaen-16-yl]acetate
   Show/Hide
C23H25NO6
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0473127
(E)-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-(4-oxo-2-phenylchromen-3-yl)prop-2-enamide
   Show/Hide
C37H34N2O5
 1
1
IC50 = 1360 nM
   TI
   LI
   LO
   TS
CP0564288
2-[(3S,14R)-12-hydroxy-3-[(1R)-1-hydroxyethyl]-14-methyl-10-oxo-15-oxa-2-azapentacyclo[9.7.1.02,6.07,19.013,18]nonadeca-1(19),6,8,11,13(18),16-hexaen-16-yl]acetic acid
   Show/Hide
C22H21NO6
 1
1
IC50 = 1440 nM
   TI
   LI
   LO
   TS
CP0564289
2-[(3S,14S,16S)-12-hydroxy-3-[(1R)-1-hydroxyethyl]-14-methyl-10,17-dioxo-15-oxa-2-azapentacyclo[9.7.1.02,6.07,19.013,18]nonadeca-1(18),6,8,11(19),12-pentaen-16-yl]acetic acid
   Show/Hide
C22H21NO7
 1
1
IC50 = 1480 nM
   TI
   LI
   LO
   TS
CP0569641
2-[(3R,14R,16S)-12-hydroxy-3-[(1R)-1-hydroxyethyl]-14-methyl-10-oxo-15-oxa-2-azapentacyclo[9.7.1.02,6.07,19.013,18]nonadeca-1(19),6,8,11,13(18)-pentaen-16-yl]acetic acid
   Show/Hide
C22H23NO6
 1
1
IC50 = 1530 nM
   TI
   LI
   LO
   TS
CP0524407
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-2-(7-methoxy-4-methyl-2-oxochromen-3-yl)acetamide
   Show/Hide
C32H34N2O6
 1
1
IC50 = 1970 nM
   TI
   LI
   LO
   TS
CP0570871
1-[(2S,5S)-2-benzyl-5-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-4-(pyridine-2-carbonyl)piperazin-1-yl]ethanone
   Show/Hide
C28H29N3O5
 1
1
IC50 = 2770 nM
   TI
   LI
   LO
   TS
CP0577511
1-[(2S,5S)-4-benzoyl-2-benzyl-5-[(7-hydroxy-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl]ethanone
   Show/Hide
C28H28N2O5
 1
1
IC50 = 3130 nM
   TI
   LI
   LO
   TS
CP0537745
1-[(2S,5S)-2-benzyl-5-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-4-(pyridine-3-carbonyl)piperazin-1-yl]ethanone
   Show/Hide
C28H29N3O5
 1
1
IC50 = 3550 nM
   TI
   LI
   LO
   TS
CP0571948
(3S,7S,8aS)-2-acetyl-3-benzyl-3'-methoxyspiro[3,4,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-7,5'-furan]-2',6-dione
   Show/Hide
C20H22N2O5
 1
1
IC50 = 4130 nM
   TI
   LI
   LO
   TS
CP0575133
1-[(2S,5S)-4-benzoyl-2-benzyl-5-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl]ethanone
   Show/Hide
C29H30N2O5
 1
1
IC50 = 4360 nM
   TI
   LI
   LO
   TS
CP0564290
(3R)-4-[(8S)-4,5-dihydroxy-8-[(1R)-1-hydroxyethyl]-3-oxo-9,10-dihydro-8H-pyrrolo[1,2-a]benzo[cd]indol-6-yl]-3-hydroxybutanoic acid
   Show/Hide
C20H21NO7
 1
1
IC50 = 4490 nM
   TI
   LI
   LO
   TS
CP0496308
1-[(2S,5S)-2-benzyl-5-[(4-hydroxy-3,5-dimethoxyphenyl)methyl]piperazin-1-yl]ethanone
   Show/Hide
C22H28N2O4
 1
1
IC50 = 4500 nM
   TI
   LI
   LO
   TS
CP0001940
(8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
   Show/Hide
C27H29NO11
 2
1
IC50 = 4900 nM
   TI
   LI
   LO
   TS
2
IC50 = 5750 nM
   TI
   LI
   LO
   TS
CP0568010
2-[(3S,15R,17R)-12-hydroxy-3-[(1R)-1-hydroxyethyl]-15-methyl-10-oxo-14,16-dioxa-2-azapentacyclo[9.8.1.02,6.07,20.013,19]icosa-1(19),6,8,11(20),12-pentaen-17-yl]acetic acid
   Show/Hide
C22H23NO7
 1
1
IC50 = 5040 nM
   TI
   LI
   LO
   TS
CP0542876
1-[(2S,5S)-4-benzoyl-2-benzyl-5-[(4-hydroxy-3,5-dimethoxyphenyl)methyl]piperazin-1-yl]ethanone
   Show/Hide
C29H32N2O5
 1
1
IC50 = 5080 nM
   TI
   LI
   LO
   TS
CP0543937
(3S,11S,11aS)-2-acetyl-3-benzoyl-11-(4-hydroxy-3,5-dimethoxyphenyl)-3,4,11,11a-tetrahydro-1H-pyrazino[1,2-b]isoquinolin-6-one
   Show/Hide
C29H28N2O6
 1
1
IC50 = 5150 nM
   TI
   LI
   LO
   TS
CP0537747
(E)-1-[(2S,5S)-4-acetyl-2,5-dibenzylpiperazin-1-yl]-3-phenylprop-2-en-1-one
   Show/Hide
C29H30N2O2
 1
1
IC50 = 5970 nM
   TI
   LI
   LO
   TS
CP0571943
1-[(2S,5S)-4-benzoyl-2,5-bis[(7-methoxy-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl]ethanone
   Show/Hide
C31H32N2O8
 1
1
IC50 = 6100 nM
   TI
   LI
   LO
   TS
CP0577027
1-[(2S,5S)-2-benzyl-5-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-4-(pyridine-4-carbonyl)piperazin-1-yl]ethanone
   Show/Hide
C28H29N3O5
 1
1
IC50 = 6180 nM
   TI
   LI
   LO
   TS
CP0535458
(E)-1-[(2S,5S)-4-acetyl-5-benzyl-2-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl]-3-phenylprop-2-en-1-one
   Show/Hide
C31H32N2O5
 1
1
IC50 = 6440 nM
   TI
   LI
   LO
   TS
CP0542877
(3S,7E,8S,8aS)-2-acetyl-7-[(4-hydroxyphenyl)methylidene]-8-(7-methoxy-1,3-benzodioxol-5-yl)-3-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-3,4,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazin-6-one
   Show/Hide
C33H32N2O9
 1
1
IC50 = 6450 nM
   TI
   LI
   LO
   TS
CP0574390
(3S,7E,8S,8aS)-2-acetyl-3-benzyl-7-[(4-hydroxy-3-methoxyphenyl)methylidene]-8-(7-methoxy-1,3-benzodioxol-5-yl)-3,4,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazin-6-one
   Show/Hide
C32H32N2O7
 1
1
IC50 = 6850 nM
   TI
   LI
   LO
   TS
CP0542872
(3R,11S,11aS)-2-acetyl-3-benzoyl-11-(4-hydroxy-3,5-dimethoxyphenyl)-3,4,11,11a-tetrahydro-1H-pyrazino[1,2-b]isoquinolin-6-one
   Show/Hide
C29H28N2O6
 1
1
IC50 = 7050 nM
   TI
   LI
   LO
   TS
CP0571944
1-[(2S,5S)-4-benzoyl-2,5-dibenzylpiperazin-1-yl]ethanone
   Show/Hide
C27H28N2O2
 1
1
IC50 = 7130 nM
   TI
   LI
   LO
   TS
CP0542873
(3S,7E,8S,8aS)-2-acetyl-3-benzyl-7-[(4-hydroxyphenyl)methylidene]-8-(7-methoxy-1,3-benzodioxol-5-yl)-3,4,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazin-6-one
   Show/Hide
C31H30N2O6
 1
1
IC50 = 7280 nM
   TI
   LI
   LO
   TS
CP0546148
(3R,7R,9R,20R)-11-hydroxy-20-[(1R)-1-hydroxyethyl]-3,7,9-trimethyl-4,8-dioxa-21-azahexacyclo[10.9.1.02,10.03,7.016,22.017,21]docosa-1,10,12(22),14,16-pentaene-5,13-dione
   Show/Hide
C24H25NO6
 1
1
IC50 = 7580 nM
   TI
   LI
   LO
   TS
CP0542878
(3S,7E,8S,8aS)-2-acetyl-7-[(4-hydroxy-3-methoxyphenyl)methylidene]-8-(7-methoxy-1,3-benzodioxol-5-yl)-3-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-3,4,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazin-6-one
   Show/Hide
C34H34N2O10
 1
1
IC50 = 7640 nM
   TI
   LI
   LO
   TS
CP0570873
(E)-1-[(2S,5S)-4-acetyl-2,5-bis[(7-methoxy-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl]-3-phenylprop-2-en-1-one
   Show/Hide
C33H34N2O8
 1
1
IC50 = 7820 nM
   TI
   LI
   LO
   TS
CP0574799
(E)-1-[(2S,5S)-4-acetyl-2,5-bis[(7-methoxy-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C34H36N2O10
 1
1
IC50 = 9070 nM
   TI
   LI
   LO
   TS
CP0396933
(3S,3'S,7R,8R,8aS)-2-acetyl-3-benzyl-8-(7-methoxy-1,3-benzodioxol-5-yl)-3'-phenylspiro[3,4,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-7,2'-oxirane]-6-one
   Show/Hide
C31H30N2O6
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0489400
(3S,7E,8S,8aS)-2-acetyl-3-benzyl-7-benzylidene-8-(7-methoxy-1,3-benzodioxol-5-yl)-3,4,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazin-6-one
   Show/Hide
C31H30N2O5
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0530790
(3S,3'S,7R,8R,8aS)-2-acetyl-8-(7-methoxy-1,3-benzodioxol-5-yl)-3-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-3'-phenylspiro[3,4,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-7,2'-oxirane]-6-one
   Show/Hide
C33H32N2O9
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0541597
(3S,7E,8S,8aS)-2-acetyl-7-benzylidene-8-(7-methoxy-1,3-benzodioxol-5-yl)-3-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-3,4,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazin-6-one
   Show/Hide
C33H32N2O8
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Lymph node)
Cell Line Name Organism Disease
AN3-CA Homo sapiens (Human) Acanthosis nigricans--NCIt; C7359; Endometrial adenocarcinoma
A2058 Homo sapiens (Human) Amelanotic melanoma
LOX-IMVI Homo sapiens (Human) Amelanotic melanoma
SW620 Homo sapiens (Human) Colon adenocarcinoma
LoVo Homo sapiens (Human) Colon adenocarcinoma
SK-MEL-5 Homo sapiens (Human) Cutaneous melanoma
SU-DHL-5 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
HOC313 Homo sapiens (Human) Floor of mouth squamous cell carcinoma
HGC-27 Homo sapiens (Human) Gastric carcinoma
NUGC-4 Homo sapiens (Human) Gastric signet ring cell adenocarcinoma
NCI-H1993 Homo sapiens (Human) Lung adenocarcinoma
PC-9 Homo sapiens (Human) Lung adenocarcinoma
NCI-H838 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1568 Homo sapiens (Human) Lung adenocarcinoma
PC9-DRH Homo sapiens (Human) Lung adenocarcinoma
NCI-H2009 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1299 Homo sapiens (Human) Lung large cell carcinoma
NCI-H1155 Homo sapiens (Human) Lung large cell carcinoma
NCI-H292 Homo sapiens (Human) Lung mucoepidermoid carcinoma
HBL-2 [Human mantle cell lymphoma] Homo sapiens (Human) Mantle cell lymphoma
MNT-1 Homo sapiens (Human) Melanoma
JR8 Homo sapiens (Human) Melanoma
MM96L Homo sapiens (Human) Melanoma
WM3629 Homo sapiens (Human) Melanoma
L3.6pl Homo sapiens (Human) Pancreatic adenosquamous carcinoma
LNCaP Homo sapiens (Human) Prostate carcinoma
LAPC-4 Homo sapiens (Human) Prostate carcinoma
LNCaP-AR Homo sapiens (Human) Prostate carcinoma
LNCaP C4-2 Homo sapiens (Human) Prostate carcinoma
MR49F Homo sapiens (Human) Prostate carcinoma
LNCaP-hr Homo sapiens (Human) Prostate carcinoma
LNCap-ARR2PB-eGFP Homo sapiens (Human) Prostate carcinoma
Th17 Mus musculus (Mouse) -